Capricor Therapeutics, Inc. (CAPR)
26.02
-1.16
(-4.27%)
USD |
NASDAQ |
Dec 12, 16:00
26.14
+0.12
(+0.46%)
After-Hours: 20:00
Capricor Therapeutics Research and Development Expense (TTM): 74.99M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 56.05M |
| Inovio Pharmaceuticals, Inc. | 55.38M |
| Arcturus Therapeutics Holdings, Inc. | 101.81M |
| AIM ImmunoTech, Inc. | 3.826M |
| Protalix Biotherapeutics, Inc. | 18.06M |